TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 380 filers reported holding TANDEM DIABETES CARE INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,902,663 | -35.1% | 145,350 | -28.1% | 0.87% | -33.3% |
| Q4 2022 | $9,092,485 | -6.9% | 202,280 | +140.8% | 1.31% | +58.8% |
| Q1 2022 | $9,768,000 | -26.9% | 84,000 | -28.7% | 0.82% | -24.8% |
| Q3 2020 | $13,370,000 | +14.5% | 117,800 | -0.2% | 1.10% | -27.4% |
| Q2 2020 | $11,673,000 | +34.4% | 118,000 | -12.6% | 1.51% | -9.4% |
| Q1 2020 | $8,687,000 | +11.2% | 135,000 | +3.1% | 1.66% | +10.4% |
| Q4 2019 | $7,809,000 | -6.8% | 131,000 | -7.7% | 1.51% | -14.5% |
| Q3 2019 | $8,375,000 | +10.9% | 142,000 | +21.4% | 1.76% | +18.9% |
| Q2 2019 | $7,549,000 | +32.1% | 117,000 | +30.0% | 1.48% | +27.7% |
| Q1 2019 | $5,716,000 | +49.0% | 90,000 | -10.9% | 1.16% | +2.8% |
| Q4 2018 | $3,835,000 | -22.1% | 101,000 | -12.2% | 1.13% | +27.9% |
| Q3 2018 | $4,926,000 | – | 115,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |